Why is Marksans Pharma falling/rising?

As of 22-Sep, Marksans Pharma Ltd is experiencing a decline in its stock price, currently at Rs 174.25, which reflects a decrease of Rs 4.9 or 2.74%. The stock has underperformed its sector by 1.66% today, with an intraday low of Rs 174, indicating a negative sentiment among investors. Over the past month, the stock has decreased by 3.09%, and its year-to-date performance shows a significant drop of 41.18%. Despite a high management efficiency indicated by a return on equity (ROE) of 17.66% and a low debt-to-equity ratio, the stock's long-term growth prospects appear poor, as evidenced by a negative annual operating profit growth rate of -0.29% over the last five years. Additionally, the company reported a substantial decline in profit after tax (PAT) in the most recent quarter, which has likely contributed to the stock's downward trend.
In the broader market context, the stock's performance has lagged behind the benchmark, with a one-year return of -45.22% compared to the Sensex's decline of only 2.82%. This stark contrast highlights the stock's underperformance relative to the market, further influencing investor sentiment negatively. The recent drop in delivery volume by 10.18% against the five-day average also suggests a decrease in investor participation, which could exacerbate the stock's price decline. Overall, while the stock is trading at a fair value compared to its peers, the combination of poor recent financial results and a lack of investor confidence has led to its current downward trajectory.